OJPM  Vol.2 No.1 , February 2012
Cervix and breast cancers in Oujda city in Eastern Morocco: Determinants and risk factors
ABSTRACT
A retrospective study was conducted in 2008 on 681 in Eastern Morocco in order to estimate the incidence of cervical and breast cancer, and to determine the social determinants and risk factors associated with these two types of cancer. Another goal of the study was to give health decision makers evidence of the necessity for early diagnosis and treatment. A questionnaire was used before the clinical gynecological examination and sampling cell for the Pap smear. Any woman with a Pap smear suspect had to do a biopsy at the reference centre. Physicians, obstetricians and midwives in the consultation process did gynecological examination and breast palpation. Patients with a suspicious nodule underwent ultrasound and mammography by radiologists on site. Gynecological samples were carried out systematically to all ever-married women to detect cancer of the cervix. Software Excel and SPSS 17 were used for data processing. Patients with high social status were more susceptible to develop breast cancer whereas women with cervical cancer were poor, belonging to a class with a low marital status of widowed or divorced having been married at an early age. The majority of women were married (81%), poor (80%) and illiterate (66%). Breastfeeding women were less affected by breast cancer than women not breastfeeding. For cervical cancer, the difference was not statistically significant. Women using contraceptives were vulnerable to both breast and cervical cancer. For cervical cancer, over 15% of women with a family history were screened positive. No relationship was found between breast cancer and family history. Taking into account regional particularities, we stress the importance of social determinants and risk factors and show that our results are consistent with those published by other researchers. Breast and cervical cancers constitute a real challenge in Morocco. Their socioeconomic burden can be reduced by early detection and treatment. The delayed diagnosis complicates the task both in terms of survival and cost of treatment. Consequently, Moroccan health authorities are urged to adopt preventive and cost effective strategies.

Cite this paper
Maamri, A. , El Hfid, M. , Chafi, A. and Boutayeb, A. (2012) Cervix and breast cancers in Oujda city in Eastern Morocco: Determinants and risk factors. Open Journal of Preventive Medicine, 2, 9-15. doi: 10.4236/ojpm.2012.21002.
References
[1]   International Agency for Research on Cancer (2008) Globocan 2008: Cancer incidence and mortality worldwide in 2008. http://globocan.iarc.fr/

[2]   Anne, M., Bernard, H. and Cuy, K. (2005) Nouveaux cahiers de l’infirmière. “Soins infirmiers en Cancérologie et Hémopathies’’. Quatrième édition Masson, Paris.

[3]   INCa (2009) La situation du cancer en France en 2009. Collection Rapports synthèses, ouvrage collectif édité par l’INCa, Boulogne Billancourt.

[4]   Erik, C., Israel, N. and Nazbanou, H. (2003) Nouveaux cahiers de l’infirmière. “Soins infirmiers en maternité et aux personnes atteintes d’affections gynécologiques’’. Troisième édition Masson, Paris.

[5]   Boutayeb, S., Boutayeb, A., Ahbeddou, N., Boutayeb, W., Essaadi, I., Tazi, M. and Errihani, H. (2010) Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco. Cost Effectiveness and Resource Allocation, 8, 16. doi:10.1186/1478-7547-8-16

[6]   RCRC (2007) Registre des cancers de la région du Grand Casablanca: Année 2004. Edition Association Lalla Salma, Rabat.

[7]   Maamri, A. (2010) Screening for cervical uterine and breast cancer in a population of women 25 - 60 years in Oujda, Morocco. Proceeding of the 32nd Annual Meeting of International Association of Cancer Registries, Okouhama, 3-5 June 2010.

[8]   Ben Abdallah, M., Achour, N., Saadi, A., Boussen, H., BenRomdhane, K., Hechiche, M., Hsairi, M., Maalej, M., Zehani, S. and Ben Ayed, F.(2009) Cancer du sein en Tunisie: Caractéristiques épidémiologiques et tendance évolutive de l’incidence. Tunis-Medindustrie, 87, 417- 425.

[9]   Boutayeb, A. and Boutayeb, S. (2005) The burden of non communicable diseases in developing countries. International Journal for Equity in Health, 4, 2. doi:10.1186/1475-9276-4-2

[10]   Afsse, T. (2011) étude d’impact sur les couts que représentent pour l’Assurance maladie certaines pathologies liées à la pollution. http://www.afssa.fr/ET/DocumentsET/impact_sanitaire_pollution_environnemental.pdf

[11]   Shapiro, S., Rosenberg, L., Hoffman, M., Truter, H., Cooper, D., Rao, S., Dent, D., Gudgeon, A., van Zyl, J., Katzenellenbogen, J. and Baillie, R. (2000) Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. American Journal of Epidemiology, 151, 396-403.

[12]   Kogevinas, M., Pearce, N., Susser, M. and Boffetta, P. (1997) Social inequalities and cancer. IARC Scientific Publications, Lyon.

[13]   Kato, I., Miura, S., Kasumi, F., Iwase, T., Tahiro, H. and Fujita, Y. (1992) A case-control study of breast cancer among Japanese women: with special reference to family history and reproductive and dietary factors. Breast Cancer Research Treatment, 24, 51-59. doi:10.1007/BF01832358

[14]   Boutayeb, A. (2011) Social determinants of reproductive health in Morocco. African Journal of Reproductive Health, 15, 57-66.

[15]   Sakka, F. and Chelly, H. (2000) Age et vécu de la pubertéchez la jeune fille tunisienne. Tunis-Medindustrie, 78, 191-194.

[16]   The Breast cancer linkage consortium (1999) Cancer risks in BRCA 2 mutation carriers. Journal of the National Cancer Institute, 91, 1310-1316.

[17]   Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet, 27, 1389-1399.

[18]   Sasco, A.J. (2003) Breast cancer and the environment. Hormone Research, 60, 50-59. doi:10.1159/000074500

[19]   Monastiri, K., Ben Ahmed, S., Presneau, N., Bignon, J.Y. and Chouchane, L. (2002) Dépistage rapide des mutations germinales du gène BRCA1 par le test de la proteine tronquée chez les familles tunisiennes. Tunis-Medindustrie, 80, 515-518.

[20]   Lambe, M. and Hsieh, C.C. (1997) Parity, age at first birth and risk of breast cancer: A population based study in Sweden. Cancer Research Treatment, 38, 305-311. doi:10.1007/BF01806150

[21]   Freudenheim, J.L. and Marshall, J.R. (1997) Lactation history and breast cancer risk. American Journal of Epidemiology, 146, 932-938.

[22]   INSERM (2008) Cancers et environnement, une expertise collective. Edition INSERM, Paris.

[23]   Skegg, D.C.G., Paul, C., Spears, G.F.S. and Williams, S.M. (1996) Progestogen-only oral contraceptives and risk of breast cancer in New Zeland. Cancer Causes Control, 7, 513-515. doi:10.1007/BF00051883

[24]   The Endogenous Hormones and Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. Journal of the National Cancer Institute, 94, 606-616. doi:10.1093/jnci/94.8.606

[25]   The Endogenous Hormones and Breast Cancer Collaborative Group (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. British Journal of Cancer, 105, 709-722. doi:10.1038/bjc.2011.254

[26]   Abdel-Rahman, H.A., Mostafa, R., Shoulah, A.R., Wassif, O.M., Sallih, M.A., El Gendy, S.D. and Abdo, A.S. (1993) An epidemiological study of cancer breast in greater Cairo. Journal of Egyptian Public Health Association, 68, 119-142.

[27]   Reeves, G. (1996) Breast cancer and oral contraceptives-The evidence so far. Cancer Causes Control, 7, 495-496. doi:10.1007/BF00051880

[28]   Maamri, A., Mbarki, F., Chafi, A. and El Hfid, M. (2010) Dépistage du cancer du sein et du col de l’utérus chez une population de femmes agées entre 25 et 60 ans. Proceeding of the 8th congress of the International Association of Epidemiology, Beyrouth, 21-23 May 2010, 22-33. doi:10.1002/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T

[29]   Chaouki, N., Bosch, F.X., Munoz, N., Meijer, C.J.L.M., el Gueddari, B., el Ghazi, A., Deacon, J., Castellsague, X. and Walboomers, J.M.M. (1998) The viral origin of cervical cancer in Rabat, Morocco. International Journal of Cancer, 75, 546-554.

[30]   Skinner, M.E.G., Parkin, D.M., Vizcaino, A.P. and Ndhlovu, A. (1993) Cancer in the African population of Bulawayo, Zimbabwe, 1963-1977. IARC Technical Report, Lyon.

[31]   Bayo, S., Parkin, D.M., Koumare, A.K., Diallo, A.N., Ba, T., Soumare, S. and Sangare, S. (1990) Cancer in Mali: 1987-1988. International Journal of Cancer, 45, 679-684. doi:10.1002/ijc.2910450418

[32]   Williams, M.A., Kenya, P.R., Mati, J.K.G. and Thomas, D.B. (1994) Risk factors for invasive cervical cancer in Kenyan women. International Journal of Epidemiology, 32, 906-912. doi:10.1093/ije/23.5.906

 
 
Top